9.495

1.88% 0.175

After Hours: 9.50 0.005 +0.05%

Cartesian Therapeutics Inc (RNAC)

Overview News Price History Option Chain Financials Discussions Forecast

Cartesian Therapeutics Inc stock is traded at $9.495, with a volume of 45,945. It is up +1.88% in the last 24 hours and down -1.91% over the past month. Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Previous Close:

$9.32

Open:

$9.49

24h Volume:

45,945

Relative Volume:

0.75

Market Cap:

$246.89M

Revenue:

$26.00M

Net Income/Loss:

$-219.71M

P/E Ratio:

-0.1907

EPS:

-49.8

Net Cash Flow:

$-51.37M

1W Performance:

-5.05%

1M Performance:

-1.91%

6M Performance:

-11.01%

1Y Performance:

-57.15%

1-Day Range:

$9.36

$9.70

1-Week Range:

$9.31

$10.48

52-Week Range:

$8.46

$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Name

Cartesian Therapeutics Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

301-348-8698

Address

7495 NEW HORIZON WAY, FREDERICK

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

RNAC's Discussions on Twitter

Compare RNAC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RNAC Cartesian Therapeutics Inc	9.495	242.34M	26.00M	-219.71M	-51.37M	-49.80
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-25	Initiated	Wedbush	Outperform
Dec-19-24	Initiated	BTIG Research	Buy
Aug-06-24	Initiated	TD Cowen	Buy
Jul-02-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-24	Initiated	Oppenheimer	Outperform
May-24-24	Initiated	Mizuho	Buy
Apr-23-24	Reiterated	H.C. Wainwright	Buy
Apr-23-24	Initiated	Leerink Partners	Outperform
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform
Jun-14-22	Reiterated	Needham	Buy
Jun-06-22	Initiated	SVB Leerink	Outperform
Jun-15-21	Initiated	BTIG Research	Buy
Jan-26-21	Upgrade	Mizuho	Neutral → Buy
Oct-01-20	Downgrade	Mizuho	Buy → Neutral
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy
Mar-30-17	Reiterated	UBS	Buy

View All

Cartesian Therapeutics Inc Stock (RNAC) Latest News

11:53 AM

Combining price and volume data for Cartesian Therapeutics Inc.July 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com

11:53 AM

10:34 AM

Is Cartesian Therapeutics Inc. stock entering bullish territoryWeekly Loss Report & Reliable Entry Point Alerts - newser.com

10:34 AM

08:17 AM

Smart tools for monitoring Cartesian Therapeutics Inc.’s price actionBull Run & Technical Pattern Based Signals - newser.com

08:17 AM

04:23 AM

Developing predictive dashboards with Cartesian Therapeutics Inc. dataQuarterly Trade Report & Precise Swing Trade Alerts - newser.com

04:23 AM

Oct 12, 2025

Will earnings trigger a reversal in Cartesian Therapeutics Inc.2025 Market WrapUp & Safe Entry Zone Tips - newser.com

Oct 12, 2025

Custom strategy builders for tracking Cartesian Therapeutics Inc.Fed Meeting & Safe Capital Allocation Plans - newser.com

Oct 12, 2025

What macro factors could drive Cartesian Therapeutics Inc. (1S70) stock higherMarket Trend Summary & Daily Technical Forecast Reports - newser.com

Oct 12, 2025

Forecasting Cartesian Therapeutics Inc. price range with options dataJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com

Oct 12, 2025

Oct 10, 2025

Will Cartesian Therapeutics Inc. (1S70) stock enhance shareholder valueAnalyst Downgrade & Pattern Based Trade Signal System - newser.com

Oct 10, 2025

How to manage a losing position in Cartesian Therapeutics Inc.Weekly Stock Summary & Entry Point Confirmation Signals - newser.com

Oct 10, 2025

Published on: 2025-10-10 06:07:33 - newser.com

Oct 10, 2025

Can trapped investors hope for a rebound in Cartesian Therapeutics Inc.2025 Macro Impact & AI Driven Stock Movement Reports - newser.com

Oct 10, 2025

Can Cartesian Therapeutics Inc. (1S70) stock expand revenue streams2025 Technical Overview & Safe Entry Zone Identification - newser.com

Oct 10, 2025

Applying big data sentiment scoring on Cartesian Therapeutics Inc.Share Buyback & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025

Will Cartesian Therapeutics Inc. (1S70) stock outperform benchmarksJuly 2025 Intraday Action & High Yield Stock Recommendations - newser.com

Oct 10, 2025

Cartesian Therapeutics Inc Stock Analysis and ForecastTechnical Resistance Breaks & Trade Like a Pro Using AI Edge - earlytimes.in

Oct 10, 2025

How to interpret RSI for Cartesian Therapeutics Inc. stockWeekly Trend Summary & Stock Portfolio Risk Management - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Cartesian Therapeutics (NASDAQ:RNAC) - MarketBeat

Oct 09, 2025

Published on: 2025-10-09 04:13:52 - newser.com

Oct 09, 2025

Oct 08, 2025